DuraSeal as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25201125.
- Also identified by DOI 10.1016/j.radonc.2014.08.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to evaluate the utility of off-label use of DuraSeal polyethylene glycol (PEG) gel in low-dose rate (LDR) prostate brachytherapy seed implantation to reduce rectal doses. Diluted DuraSeal was easy to use and, in spite of a clearance effect, useful in decreasing D₂cc rectal doses.
Medical subject headings
- Brachytherapy
- Prostatic Neoplasms
- Radiation-Protective Agents
- Rectum
- Resins, Synthetic